SY

Sneha Yallaraddi Dudyal

Active Director Director DIN 09055997
DIN 09055997 First appointment Feb 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2021
Shareholding value •••• Premium profile

About Sneha Yallaraddi Dudyal

Data last updated:

Sneha Yallaraddi Dudyal is a Director at Wellspring Pharmaceutical Private Limited (since 2021). The company operates in Pharma. Wellspring Pharmaceutical Private Limited reported revenue of ₹2.50 Cr (FY 2025).

DIN 09055997
Primary Designation Director
Industry Pharma
First Appointment 06 Feb 2021
Oldest Company Age 10 yrs
Largest company Wellspring Pharmaceutical Private Limited · ₹2.50 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Feb 20212016₹2.50 Cr (FY 2025)Active

Board colleagues of Sneha Yallaraddi Dudyal

Directorship timeline

Open interactive timeline →
Wellspring Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Sneha Yallaraddi Dudyal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sneha Yallaraddi Dudyal

Sneha Yallaraddi Dudyal currently holds 1 directorship: Wellspring Pharmaceutical Private Limited (Director, since 06 Feb 2021, revenue ₹2.50 Cr (FY 2025)).

Sneha Yallaraddi Dudyal was first appointed on 06 Feb 2021 as Director at Wellspring Pharmaceutical Private Limited.

The current boards of Sneha Yallaraddi Dudyal's companies include Shashank Rajendra Bidari (Wellspring Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available